Don't wanna be here? Send us removal request.
Statistics
We looked inside some of the posts by tejasarekar0904-blog and here's what we found interesting.
Average Info
Notes Per Post
0
Likes Per Post
0
Reblog Per Post
0
Reply Per Post
0
Time Between Posts
2 hours
Number of Posts By Type
Text
4
Link
13
Last Seen Tumblr Blogs
Fun Fact
If you dial 1-866-584-6757, you can leave an audio post for your followers.
Text
Non Invasive Prenatal Testing Market| Market Trends by Instruments, Consumables, Method, Application and End User
The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.
The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021.
The instruments segment is divided into ultrasound device, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT.
Based on application, the market is divided into Trisomy, microdeletion syndrome, and other applications. Trisomy forms the largest and fastest-growing application segment of the global market. This is mainly attributed to the rising incidence of chromosomal abnormalities with increasing maternal age.
The global market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The market in Asia is expected to grow at the highest CAGR during the forecast period. Factors such as increasing awareness programs, high incidence of genetic disorders, increasing healthcare infrastructure, and rising disposable income are some of the factors contributing to the growth of the market in Asia.
Key Players:
Key market players are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).
Get More Details @ https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html
0 notes
Text
Gas Chromatography Market |Market Analysis by Instrument, Accessories and Consumables, End User with Key Players
In this report, the gas chromatography market is segmented on the basis of instruments, accessories and consumables, end users, and regions. The instruments market is segmented into systems, detectors, auto-samplers, and fraction collectors. The systems segment is projected to register the highest CAGR during the forecast period. The growth of this segment can primarily be attributed to factors such as increased capability to analyze complex compounds and technological advancements.
The global gas chromatography market is expected to reach USD 3.67 Billion by 2022 from USD 2.64 Billion in 2016, at a CAGR of 6.2%.
On the basis of accessories and consumables, the market is segmented into columns, column accessories, auto-sampler accessories, flow management consumables & accessories, fittings & tubing, pressure regulators, gas generators, and other accessories. The columns segment is expected to be the fastest-growing of the global gas chromatography market during the forecast period. The growth of this segment can primarily be attributed to factors such as discovery of new oil fields and the availability of improved gas chromatography columns for the petroleum industry.
On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific, and the RoW. Of these, North America accounted for the largest market share in 2016. Factors such as increase in the U.S. shale gas production, growing funding for environmental testing and clean-up in Canada, increasing funding for R&D activities in healthcare & environmental industries, and growing food testing industries are driving the growth of the North American gas chromatography market.
Key Players:
Key players in this market include Agilent Technologies, Inc. (U.S), Thermo Fisher Scientific, Inc. (U.S), Shimadzu Corporation (Japan), PerkinElmer, Inc. (U.S), Danaher Corporation (U.S), Scion instruments (Techcomp USA Inc.), Leco corporation (U.S), Merck KgaA (Germany), Falcon Analytical Systems &Technology, LLC (U.S), Restek Corporation (U.S), Dani Instruments S.P.A. (Italy) and Chromatotec (France). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.
Get More Analysis @ https://www.marketsandmarkets.com/Market-Reports/gas-chromatography-market-101656773.html
0 notes
Link
The overall high content screening market is expected to grow from USD 506.7 million in 2016 to USD 909.0 million by 2022, at a CAGR of 10.3% from 2017 to 2022.
0 notes
Link
The overall pharmaceutical robotic systems market is expected to grow from USD 64.37 million in 2016 to USD 119.46 million by 2021, at a CAGR of 13.2% from 2016 to 2021.
0 notes
Link
The overall pharmacy automation market is estimated to grow at a CAGR of 8.2% from 2017 to 2022 to reach USD 5.38 Billion by 2022.
0 notes
Link
The overall gas chromatography market is expected to reach USD 3671.0 million by 2022 from USD 2647.0 million in 2016, at a CAGR of 6.2%.
0 notes
Link
The global computer-assisted coding market is valued at USD 2.76 billion in 2017 and is expected to register a CAGR of 11.5% to reach to USD 4.75 billion by 2022.
0 notes
Link
The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 9.42 billion in 2017, at a CAGR of 10.6% during the forecast period.
0 notes
Text
High Content Screening Market : Strategies adopted by Major Players
The global high-content screening (HCS) market is consolidated in nature with the top five players commanding a major share of the market. GE Healthcare (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Becton, Dickinson and Company (U.S.) lead the global market. Some of the other leading players in this market include BioTek Instruments Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Tecan Group Ltd. (Switzerland), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).
The global high-content screening market is expected to reach USD 909.0 Million by 2022 from USD 557.1 Million in 2017, at a CAGR of 10.3%.
Danaher Corporation holds a leading position in the market. The company designs, manufactures, and markets professional, medical, industrial, and commercial products & services. Danaher Corporation primarily focuses on product launches as its key business strategy. For example, in February 2017, Molecular Devices, LLC (U.S.), a subsidiary of Danaher Corporation, launched the SpectraMax iD3 Multi-Mode Microplate Reader. This added another platform to the company’s portfolio to expand its reach in the HCS market. In April 2016, Molecular Devices, LLC (U.S.) launched the ImageXpress Micro 4 High-content Imaging System. This further strengthened the company’s HCS product portfolio.
High-content screening (HCS) is a method that is used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner. High-content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters.
Based on product, the global high content screening market is broadly segmented into instruments, consumables, software, services, and accessories. The market for HCS software is expected to grow at the highest CAGR between 2017 and 2022. Among all high content screening products, instrument segment caters to the largest share. The large share of this segment is attributed to advances in instrumentation and automation techniques and high prices of HCS instruments.
Know about market Details @ https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html
0 notes
Text
Non-invasive Prenatal Testing Market :Lucrative Business Growth Opportunities
The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period.
The non-invasive prenatal testing market is witnessing significant growth across the globe owing to factors such as high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, launch of new and advanced products, improving reimbursement scenario for NIPT, and programs focusing on increasing the awareness of NIPT. The increasing use of NIPT in detection of Trisomy (Down syndrome, Edwards’s syndrome, and Patau syndrome), Microdeletion syndrome, and other applications (Monogenic disorders, Klinefelter syndrome, gender detection, and rhesus (Rh) blood type) also play a vital role in the development of this market. Key players in the market focus on partnerships, collaborations, and agreements; product launches, expansions; and acquisitions to strengthen their positions in the global market.
The NIPT market is segmented based on product, method, application, end user, and region. On the basis of product, the market is segmented into consumables and instruments. The consumables segment offer lucrative growth opportunities and represent a new revenue pocket for the market owing to the repeated requirements of consumables in NIPT. The consumables segment is further divided into assay kits & reagents and disposables. The instruments segment is classified into ultrasound devices, NGS systems, PCR instruments, microarrays, and other instruments.
https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html
Currently, North America dominates the market, followed by Europe. However, the market in Asia is expected to witness the highest growth due to the increasing healthcare infrastructure. In addition, increasing awareness programs, rising disposable income, and increasing interest of players to expand in these emerging economies will propel the growth of the market.
0 notes
Link
Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022
0 notes
Link
Computer Assisted Coding Market [By Software (Natural Language Processing, Structured Input, Integrated Systems), Service (Support, Education & Training), By Application (Automated Encoding, Clinical Coding Audit, Management Reporting)] Global Forecast To 2022
For more Details @ https://www.marketsandmarkets.com/Market-Reports/computer-assisted-coding-market-170644018.html
0 notes
Link
Gas Chromatography Market by Instrument (Systems, Detectors), Accessories and Consumables (Columns, Column accessories, Pressure regulators, Gas generators), End user (Oil & Gas industry, Environmental agencies, Pharma & Biotech) - Global Forecast to 2022
To get more @ https://www.marketsandmarkets.com/Market-Reports/gas-chromatography-market-101656773.html
0 notes
Link
Pharmacy Automation Market by Product (Medication Dispensing System (Robot, Carousel), Packaging & Labeling System (Unit Dose, Multi Dose), Tabletop Counter, Storage System), End User (Inpatient, Outpatient, Retail Pharmacy) - Global Forecast to 2022
http://www.marketsandmarkets.com/Market-Reports/pharmacy-automation-systems-market-71522890.html
0 notes
Link
Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=210985096
Factors such as the increase in domestic industrial robot companies, flourishing pharmaceutical industry, increasing number of conferences and exhibitions, investment and funding in the robots industry, and Japan's Robot Strategy are driving the growth of the APAC Pharmaceutical Robots Market.
0 notes
Link
Speak To Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=132685525
On the basis of application, the market is segmented into diagnostics, drug discovery and development, immunology, oncology, and other applications. In 2016, the drug discovery and development segment is expected to command the largest share and grow at the highest CAGR during the forecast period. The large share and high growth in this segment can be attributed to the increase in R&D activities for the development of novel drugs and therapies.
0 notes
Link
Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021
0 notes